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A b s t r a c t
Introduction: Colonoscopy has been widely regarded as the gold standard in 
colorectal cancer (CRC) screening. Within recent years different endoscopic 
imaging techniques have been introduced to improve the quality of colonos-
copy. The adenoma detection rate (ADR) is the single most important quality 
indicator for colonoscopy. The aim of this study was to evaluate the quality 
of CRC screening expressed by ADR in two different eras of endoscopic tech-
nology advancement.
Material and methods: We conducted a dual-center study that enrolled 
24 055 patients, who underwent colonoscopy as part of a national screening 
program. Patients were sorted into two groups according to the advance-
ment of endoscopic equipment used for colonoscopic examination: group I 
– 10 405 patients examined between 2004 and 2008 (standard electronic 
endoscopes); group II – 13 650 patients examined between 2009 and 2014 
(modern endoscopes). The ADR in two different eras and the impact of en-
doscopic novelties were determined.
Results: The ADR in group I was 29.14%, in group II 31.73% (p < 0.001). The 
overall ADR was 30.88% – 38.80% and 25.95% (p < 0.001) for the male and 
female patients, respectively. The mean adenoma number per colonoscopy 
was 0.366 (95% CI: 0.357–0.375; p < 0.001), 0.337 (0.321–0.352) and 0.380 
(0.369–0.392) for patients in group I and group II, respectively.
Conclusions: Our study shows that technological innovation, novel endosco-
py devices and diagnostic techniques improve the quality in CRC screening 
by increasing the ADR. However, we need to determine which of the tech-
nologies are supreme to achieve excellence in colorectal cancer screening.
Key words: cancer, adenoma, screening, technology, quality, colorectal, 
endoscopy, detection, rate, adenoma detection rate.
Introduction
Colorectal cancer (CRC) is the third most common cancer worldwide 
and the second most common in Europe and the United States. It con-
stitutes approximately 10% of all cancers observed in men and women 
[1–3]. Over 90% of CRC cases follow an adenoma-to-cancer sequence 
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over many years [4]. Colorectal cancer screening 
has been successful in reducing the incidence and 
mortality of CRC by increasing the proportion diag-
nosed at an early stage and facilitating removal of 
pre-neoplastic lesions [5]. Colonoscopy is current-
ly the preferred method for screening, decreasing 
the incidence of CRC by up to 80% [6, 7]. This 
beneficial effect is strongly associated with the 
adenoma detection rate (ADR), which is the sin-
gle most important quality surrogate for screening 
colonoscopy. The definition of ADR suggested by 
the English Bowel Cancer Screening Programme 
is the number of colonoscopies at which one or 
more histologically confirmed adenomas is found 
divided by the total number of colonoscopies per-
formed. According to the most recent European 
Society of Gastrointestinal Endoscopy (ESGE) rec-
ommendations, ADR should be at the minimum 
level of 25%. The goal of the modern colonosco-
py quality improvement is to reduce the operator 
dependence, and generally to move low-level per-
formers toward high-end performance as rapidly 
as possible. 
Poor cecal intubation rate (CIR) correlates with 
a  low adenoma detection rate, and it is closely 
associated with an increased risk of post-colo-
noscopy colorectal cancer (PCCRC). Within recent 
years different endoscopic imaging techniques 
have been introduced to improve the quality of 
colonoscopy and CRC screening. We have wit-
nessed the transition from fiberscopes to video-
scopes, which already has significantly increased 
the diagnostic capability of endoscopes. Follow-
ing the introduction of videoscopes, the structure 
of the endoscopes has been changed nowadays. 
Responsive insertion technology (RIT) combines 
three technologies, passive bending (PB), high-
force transmission (HFT), and variable stiffness, 
to facilitate the feasibility of the examination, 
increasing the CIR, and increasing the patient’s 
comfort. The new endoscopes also include nar-
row band imaging (NBI), near focus (NF) and 
magnetic endoscopic imaging (MEI) – novelties 
that are supposed to reduce the adenoma miss 
rate. 
Our aim was to evaluate the quality of colo-
noscopy expressed by ADR in two different eras of 
endoscopic technology advancement. 
Material and methods
We conducted a  retrospective dual-center 
study in the 2nd Department of Surgery, Jagiello-
nian University Medical College and the Specialist 
Diagnostic and Therapeutic Center “Medicina” in 
Krakow, Poland. The study was approved by the 
local ethics committee and conducted in accor-
dance with the principles of the Declaration of 
Helsinki (KBN no. 122.6120.36.2016).
Patients
We selected 24 055 patients aged 40-65 who 
underwent colonoscopy screening between Janu-
ary 2000 and December 2014 (as part of a nation-
al colorectal cancer screening program, which was 
financed by the Polish Ministry of Health). Patients 
with a prior history of abdominopelvic surgery, in-
flammatory bowel disease, active malignancy, and 
a high anesthetic risk (ASA IV) were excluded from 
the study. All patients were pre-evaluated before 
the examination and written informed consent for 
the procedure was obtained. Bowel preparation 
was accomplished using verbal and written infor-
mation. Patients were informed to take a  liquid 
propulsive agent (i.e., 420 g of polyethylene glycol 
(PEG) in 4 l of water) in the evening prior to the 
procedure for morning patients and a  split-dose 
regimen for those in the afternoon schedule. 
Setting
We used Olympus series colonoscopes (Olym-
pus Optical Co. Ltd, Tokyo, Japan). Patients were 
sorted into two groups according to the endoscop-
ic equipment used for colonoscopic examination. 
Group I included 10 405 patients examined be-
tween 2004 and 2008. This era encompasses the 
use of electronic endoscopes with a standard res-
olution (CF-Q145, CF-Q165, and CF-Q180). 
Between 2009 and 2014, we performed 13 650 
colonoscopies using the CF-HQ190L (group II). 
This was the era of endoscopes with a high-defi-
nition resolution, magnetic scope guide, respon-
sive insertion technology (RIT) and narrow band 
imaging (NBI) with dual focus two-stage optical 
lens technology (Table I). 
Patients’ preoperative characteristics including 
demographics, body mass index (BMI), family his-
tory of malignancy and significant comorbidities 
were determined. 
Outcome
Ten experienced endoscopists conducted 
the procedures, each having independently per-
formed over 1000 colonoscopies, certified by the 
Polish Society of Surgeons. The ADR was deter-
mined as the number of colonoscopies in which 
one or more histologically confirmed adenomas 
were found divided by the total number of colo-
noscopies performed. We compared the ade-
noma detection rate (ADR) and mean adenoma 
number per colonoscopy in two successive eras 
of endoscopic technological development ac-
cording to the series of the endoscope used. We 
compared the procedures per room ratio (PPR – 
a parameter that describes the approximate ca-
pacity of procedures per room, representing the 
mean number of procedures done daily in one 
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colonoscopy office). Other endpoints of the study 
influencing the ADR were analyzed: complete-
ness of examination, bowel preparation assess-
ment (5-point scale), and patient tolerance for 
examination (4-point scale). Pathological results 
were also presented.
Statistical analysis
All data were analyzed with StatSoft Statistica 
v.12.5 (StatSoft Inc, Tulsa, Oklahoma, USA). The 
results are presented as mean ± standard de-
viation (SD), or median and interquartile range 
(IQR), when appropriate. The study of categorical 
variables used Pearson’s c2 test, or c2 with Yates 
correction when appropriate. The Shapiro-Wilk 
test was used to check for normal distribution of 
data. Quantitative data were analyzed with Stu-
dent’s t-test (for normally distributed data) or the 
Mann-Whitney test (for non-normally distributed 
data). Univariate and multivariate logistic regres-
sion models were built including continuous and 
categorical variables. Results were considered sta-
tistically significant when the p-value was found 
to be less than 0.05.
Results
We observed no difference between the groups 
regarding sex and age (p = 0.790 and 0.404, re-
spectively). Body mass index was slightly higher in 
group II (p < 0.001). Family history of malignancy 
was more prevalent in group II (43% vs. 41.18%, 
p = 0.010). Patients in this group had more sig-
nificant comorbidities than in group I (21.87% vs. 
8.89%, p < 0.001). Complete colonoscopies were 
performed more frequently in group II (96.68% vs. 
93.73%, p < 0.001) and the adenoma detection 
rate was higher in group II (31.73% vs. 29.14%, 
p < 0.001) along with mean adenoma number 
per colonoscopy (p < 0.001). Procedures per room 
ratio (PPR) was comparable (p = 0.088). Patients 
in groups I  and II differed slightly, yet statisti-
cally significantly, in terms of bowel preparation 
and tolerance of examination (p < 0.001). Bowel 
preparation assessment was classified as follows: 
1 – poor, 2 – substandard, 3 – adequate, 4 – good, 
5 – excellent. Patients’ tolerance of colonoscopy 
was described as follows: 1 – severe discomfort, 
2 – moderate discomfort, 3 – mild discomfort, 
4 – no or minimal discomfort. Basic characteristics 
and comparison between group I and group II are 
presented in Table II.
Table III presents univariate logistic regression 
analysis of influence of selected factors on com-
pleteness of examinations. Significant factors 
were patients’ sex, age, BMI, bowel preparation, 
tolerance and examination performed in group II. 
They were included in multivariate logistic re-
gression in Table IV. Multivariate logistic regres-
sion analysis of the influence of selected factors 
on completeness of examinations revealed that 
patients’ sex, BMI, bowel preparation, tolerance 
and colonoscopy performed in the era of modern 
endoscopes were significant independent factors 
that resulted in completeness of examinations.
Univariate logistic regression analysis of the 
influence of selected factors on the adenoma de-
tection rate (ADR) is presented in Table V. Male 
sex, age, BMI, bowel preparation, completeness of 
examinations, patient’s tolerance for examination 
and colonoscopies performed in group II increased 
ADR. Then significant factors were included in the 
multivariate logistic regression analysis presented 
in Table VI: male sex, age, BMI, bowel preparation, 
completeness of examinations and examinations 
performed in the modern endoscope era (group II) 
increased ADR as independent factors.
The overall ADR was 30.88–38.80% and 25.95% 
for the male and female patients, respective-
ly. The mean adenoma number per colonoscopy 
was 0.366 (95% CI: 0.357–0.375) – 0.483 (0.466–
Table I. Parameters of endoscopes used in the 
study
Endoscopes used in group I (2004–2008)
Olympus CF-Q145:
•	 Diameter: 12.8 mm
•	 Working length: 168 cm
•	 Instrument channel: 3.7 mm
•	 Field of view: 140°
•	 Angulation range: up: 180, down: 180, right: 160, 
left 160
Olympus CF-Q165:
•	 Diameter: 12.8 mm
•	 Working length: 168 cm
•	 Instrument channel: 3.7 mm
•	 Field of view: 140°
•	 Angulation range: up: 180, down: 180, right: 160, 
left 160
Olympus CF-Q180:
•	 Diameter: 12.8 mm
•	 Working length: 168 cm
•	 Instrument channel: 3.7 mm
•	 Field of view: 170°
•	 Angulation range: up: 180, down: 180, right: 160, 
left 160
•	 Features: variable stiffness technology
Endoscopes used in group II (2009–2014)
Olympus CF-HQ190L:
•	 Diameter: 12.8 mm
•	 Working length: 168 cm
•	 Instrument channel: 3.7 mm
•	 Field of view: 170°, near 160°
•	 Angulation range: up: 180, down: 180, right: 160, 
left 160
•	 Features: variable stiffness technology, narrow band 
imaging (NBI), responsive insertion technology (RIT), 
scope guide, high definition (HD) (1280 × 1024 pixels)
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0.500) and 0.290 (0.280–0.301) for the male and 
female patients, respectively.
Table VII presents the adenoma detection rate 
in relation to specific factors that influenced ADR 
in the logistic regression model.
Tables VIII and IX present comparisons of his-
topathological findings respectively in distal and 
proximal colon between groups with p-values of 
inter-group comparisons.
Table II. Comparison between groups
Parameter All Group I Group II P-value
Sex M/F, n (%) 9007/13841 
(39%/61%)
2881/4404 
(40%/60%)
6126/9437 
(39%/61%)
0.790
Age, mean ± SD [years] 54 ±7 54 ±6 54 ±7 0.404
BMI, mean ± SD [kg/m2] 26.87 ±4.74 26.56 ±3.9 26.97 ±4.97 < 0.001
Malignancy in family history, n (%) 9692 (42.42) 3000 (41.18) 6692 (43.00) 0.010
Significant comorbidity, n (%) 4051 (17.73) 648 (8.89) 3403 (21.87) < 0.001
Full/incomplete examinations, n (%) 21875/973 
(95.74/4.26)
6828/457 
(93.73/6.27)
15047/516 
(96.68/3.32)
< 0.001
PPR 10.29 ±6.88 9.95 ±6.22 10.46 ±7.17 0.088
Adenoma detection rate – ADR (%) 30.88 29.14 31.73 < 0.001
Adenoma number per colonoscopy, 
mean ± SD (95% CI)
0.366 ±0.715
(0.357–0.375)
0.337 ±0.683 
(0.321–0.352)
0.380 ±0.728 
(0.369–0.392)
< 0.001
Bowel preparation assessment*, n (%):
5 20726 (90.71) 6824 (93.67) 13902 (89.27) < 0.001
4 377 (1.65) 86 (1.18) 291 (1.87)
3 712 (3.12) 266 (3.65) 446 (2.87)
2 271 (1.19) 90 (1.24) 181 (1.16)
1 67 (0.29) 19 (0.26) 48 (0.31)
Patient tolerance for exam*, n (%):
4 21838 (95.58) 6988 (95.92) 14850 (95.42) < 0.001
3 305 (1.33) 117 (1.61) 188 (1.21)
2 265 (1.16) 63 (0.86) 202 (1.30)
1 305 (1.33) 117 (1.61) 188 (1.21)
PPR – procedures per room, parameter that describes approximate capacity of procedures per room, representing mean number of 
procedures done daily in one colonoscopy office. *Bowel preparation assessment classification: 1 – poor, 2 – substandard, 3 – adequate, 
4 – good, 5 – excellent. **Patient tolerance of colonoscopy classification: 1 – severe discomfort, 2 – moderate discomfort, 3 – mild 
discomfort, 4 – no or minimal discomfort.
Table III. Univariate logistic regression analysis of influence of selected factors on completeness of examinations
Parameter OR 95% CI P-value
Sex, M vs. F 0.43 0.37–0.51 < 0.001
Age, with every year 0.99 0.98–0.99 0.049
BMI, with every 1 kg/m2 0.93 0.91–0.95 < 0.001
Significant comorbidity 1.05 0.47–2.34 0.905
Bowel preparation assessment, with every grade higher 1.95 1.88–2.02 < 0.001
Patient tolerance for exam, with every grade higher 4.52 4.19–4.87 < 0.001
Group 1 vs. 2 1.95 1.71–2.22 < 0.001
OR – odds ratio, CI – confidence interval.
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Table IV. Multivariate logistic regression analysis of influence of selected factors on completeness of examinations
Parameter OR 95% CI P-value
Sex, M vs. F 0.59 0.49–0.71 < 0.001
BMI, with every 1 kg/m2 0.96 0.94–0.98 < 0.001
Bowel preparation assessment, with every grade higher 2.11 1.94–2.29 < 0.001
Patient tolerance for exam, with every grade higher 4.67 4.28–5.10 < 0.001
Group 1 vs. 2 1.91 1.60–2.27 < 0.001
OR – odds ratio, CI – confidence interval.
Table V. Univariate logistic regression analysis of influence of selected factors on ADR
Parameter OR 95% CI P-value
Sex, F vs. M 1.82 1.69–1.92 < 0.001
Age, with every year 1.03 1.02–1.04 < 0.001
BMI, with every 1 kg/m2 1.03 1.02–1.04 < 0.001
Significant comorbidity 1.06 0.98–1.15 0.124
Bowel preparation assessment, with every grade higher 1.19 1.11–1.27 < 0.001
Patient tolerance for exam, with every grade higher 1.31 1.20–1.43 < 0.001
Completeness of examinations 2.09 1.73–2.53 < 0.001
Group 1 vs. 2 1.13 1.05–1.22 0.001
OR – odds ratio, CI – confidence interval.
Table VI. Multivariate logistic regression analysis of influence of selected factors on ADR
Parameter OR 95% CI P-value
Sex, F vs. M 1.82 1.69–1.96 < 0.001
Age, with every year 1.03 1.02–1.04 < 0.001
BMI, with every 1 kg/m2 1.02 1.01–1.03 < 0.001
Bowel preparation assessment, with every grade higher 1.17 1.09–1.26 < 0.001
Patient tolerance for exam, with every grade higher 1.06 0.95–1.18 0.271
Completeness of examinations 1.79 1.41–2.26 < 0.001
Group 1 vs. 2 1.13 1.04–1.22 0.004
OR – odds ratio, CI – confidence interval.
Discussion
The single most important outcome to mea-
sure the effectiveness of colonoscopy is the ADR, 
since it is associated with the future risk of CRC 
occurrence and mortality. Physicians performing 
screening colonoscopies with ADR below 20 % are 
more likely to have patients subsequently pre-
senting interval cancer [8]. 
Our results have confirmed some particular cir-
cumstances that without a doubt should be main-
tained to keep the quality of the examinations at 
the highest possible level. Effective bowel cleans-
ing is one of them. The better the bowel prepara-
tion is, the more precise is detection of preneo-
plastic lesions and the easier is cecal intubation. 
Poor cleansing of the bowel is associated with 
prolonged procedures and low ADR. There is het-
erogeneity among the studies concerning bowel 
cleansing as to whether split or non-split prepara-
tion is more effective. However, tolerance of high 
volumes of polyethylene glycol (PEG) solution may 
be low. Splitting the dose may improve it [9]. Au-
thors are now also focusing on the timing of bow-
el cleansing. The outcome of cleansing appears to 
be efficient when the examination is commenced 
within hours of the bowel preparation [10]. The 
bowel cleansing in our study met the criteria of 
the European Society of Gastrointestinal Endosco-
py, according to which no more than 10 % of the 
examinations should need to be repeated due to 
inadequate bowel preparation.
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Patient-related aspects also have an impact 
on ADR. Obesity is an independent risk factor of 
adenoma occurrence. There is a debate concern-
ing body weight and the technical struggle in 
reaching the cecum during colonoscopy. There is 
evidence suggesting that both low and high BMI 
patients are technically demanding for a physician 
performing the examination [11]. Obesity is also 
associated with poor bowel preparation, which 
can subsequently lead to a difficult and prolonged 
colonoscopy. Our study has revealed that a higher 
BMI was a factor associated with statistically sig-
nificantly higher ADR and a higher cecal intuba-
tion rate (CIR). It might be due to the low muscle 
content of a low-BMI patient that may predispose 
to loop formation and patient intolerance, which 
leads to unsuccessful colonoscopy. There are 
studies which revealed that the number of loops 
formed during the insertion of the endoscope in 
low-BMI patients is higher than that in obese pa-
tients [12]. 
The ADR varies between men and women. Ad-
enomas are more common in men, which explains 
our outcome that male sex is an independent fac-
tor leading to higher ADR. The American Society 
for Gastrointestinal Endoscopy (ASGE) recommen-
dations propose that adenomas should be de-
tected in more than 25% of asymptomatic male 
individuals (> 50 years) and in more than 15% of 
asymptomatic female individuals (> 50 years) at 
first. According to studies based on large popula-
tions of patients, factors associated with comple-
tion of the colonoscopy without sedation include 
male sex. That explains the higher cecal intubation 
rate among males in our study [13]. ADR as well 
as the advanced cancer detection also increases 
with age. Both men and women with each decade 
of life after 50 have a statistically higher ADR [14].
Several studies have shown that even certified 
colonoscopists exhibit variation in the adenoma 
detection rate. The difference in detecting serrat-
ed lesions is even greater than for conventional 
adenomas. It demonstrates that colonoscopy is 
a  highly operator-dependent procedure [15, 16]. 
That is why training in differentiation skills is es-
sential. 
The benefit of knowing our own ADR may also 
motivate endoscopic quality improvement, as it 
has been shown in several interventional studies 
with the implementation of scheduled personal-
ized ADR report cards [17, 18]. It has been con-
firmed in recent studies, including a  meta-anal-
ysis, where patients were undergoing same-day, 
back-to-back (tandem) colonoscopies, that es-
pecially in the right colon polyps are more likely 
to be missed [19, 20]. Of course failure to reach 
the cecum leads to low ADR in the right colon 
as a consequence of excessive loop formation or 
failure to traverse angulated, fixed, or strictured 
sigmoids (most commonly among female patients 
with prior gynecological surgery and patients with 
advanced diverticular disease). Even if the cecum 
is intubated successfully, there are factors increas-
ing the adenoma miss rate such as localization 
behind the folds and flat lesions [21, 22]. 
Using an effective technique means performing 
endoscopy with a withdrawal time allowing a phy-
sician to keep his ADR level high. There is a strong 
association of detection of precancerous lesions 
with withdrawal time. There are studies showing 
Table VII. Comparison of ADR in selected param-
eters
Parameter ADR (%) P-value
Sex, F vs. M 25.95/38.80 < 0.001
Age [years]:
50–55 27.82 < 0.001
56–60 32.08
61–65 33.43%
BMI [kg/m2]:
< 25 28.17 < 0.001
25–30 31.71
30–35 34.60
≥ 35 36.82
Significant comorbidity, 
Yes/no
31.96/30.62 0.132
Malignancy in family, 
Yes/no
31.09/30.82 0.751
Bowel preparation assessment*:
5 32.26 < 0.001
4 23.86
3 23.65
2 30.10
1 11.54
Patient tolerance for exam**:
4 31.32 < 0.001
3 22.19
2 21.13
1 18.35
Complete vs. incomplete 
examination 
31.47/18.01 < 0.001
Group 1 vs. 2 29.14/31.73 0.001
*Bowel preparation assessment classification: 1 – poor, 2 – 
substandard, 3 – adequate, 4 – good, 5 – excellent. **Patient 
tolerance of colonoscopy classification: 1 – severe discomfort, 
2 – moderate discomfort, 3 – mild discomfort, 4 – no or minimal 
discomfort.
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Table VIII. Comparison of histopathological findings in distal colon between groups
Parameter All Group I Group II P-value
Total number of exams with samples for 
pathological exam
3501 (15.32%) 1187 (16.29%) 2337 (15.02%) 0.013
Non-neoplastic lesions 1509 (6.60%) 559 (7.67%) 950 (6.10%) < 0.001
Hyperplastic polyp 422 (1.85%) 141 (1.94%) 281 (1.81%) 0.497
Benign non-epithelial neoplasm 123 (0.54%) 36 (0.49%) 87 (0.56%) 0.532
1–2 Tubular adenomas < 10 mm 1059 (4.63%) 283 (3.88%) 776 (4.99%) < 0.001
3–4 Tubular adenomas < 10 mm 29 (0.13%) 5 (0.07%) 24 (0.15%) 0.135
≥ 5 Tubular adenomas < 10 mm 3 (0.01%) 0 3 (0.02%) –
Tubular adenoma ≥ 10 mm 97 (0.42%) 38 (0.52%) 59 (0.38%) 0.122
1–2 Tubular-villous adenomas < 10 mm 58 (0.25%) 24 (0.33%) 34 (0.22%) 0.120
≥ 5 Tubular-villous adenomas < 10 mm 1 (< 0.01%) 1 (0.01%) 0 –
Tubular-villous adenoma ≥ 10 mm 34 (0.15%) 16 (0.22%) 18 (0.12%) 0.057
Villous adenoma < 10 mm 4 (0.02%) 2 (0.03%) 2 (0.01%) 0.810
Villous adenoma ≥ 10 mm 3 (0.01%) 3 (0.04%) 0 –
Polyp with high grade dysplasia < 10 mm 54 (0.24%) 22 (0.30%) 32 (0.21%) 0.211
Polyp with high grade dysplasia ≥ 10 mm 28 (0.12%) 8 (0.11%) 20 (0.13%) 0.862
Invasive adenocarcinoma in polyp 6 (0.03%) 3 (0.04%) 3 (0.02%) 0.607
Non-epithelial malignant neoplasm 1 (< 0.01%) 0 1 (0.01%) –
Macroscopic adenocarcinoma 70 (0.31%) 23 (0.32%) 47 (0.30%) 0.861
Table IX. Comparison of histopathological findings in proximal colon between groups
Parameter All Group I Group II P-value
Total number of exams with samples for 
pathological exam
12943 (56.65%) 4618 (63.39%) 8325 (53.49%) < 0.001
Non-neoplastic lesions 8331 (36.46%) 3086 (42.36%) 5245 (33.70%) < 0.001
Hyperplastic polyp 1957 (8.57%) 658 (9.03%) 1299 (8.35%) 0.084
Benign non-epithelial neoplasm 44 (0.60%) 17 (0.23%) 27 (0.17%) 0.336
1–2 Tubular adenomas < 10 mm 1483 (20.36%) 413 (5.67%) 1070 (6.88%) 0.006
3–4 Tubular adenomas < 10 mm 44 (0.19%) 13 (0.18%) 31 (0.20%) 0.739
≥ 5 Tubular adenomas < 10 mm 11 (0.05%) 3 (0.04%) 8 (0.01%) 0.996
Tubular adenoma ≥ 10 mm 286 (1.25%) 119 (1.63%) 167 (1.07%) < 0.001
1–2 Tubular-villous adenomas < 10 mm 148 (0.65%) 64 (0.88%) 84 (0.54%) 0.003
3–4 Tubular-villous adenomas < 10 mm 4 (0.02%) 3 (0.04%) 1 (0.01%) 0.189
Tubular-villous adenoma ≥ 10 mm 107 (0.47%) 52 (0.71%) 55 (0.35%) < 0.001
Villous adenoma < 10 mm 4 (0.02%) 3 (0.04%) 1 (0.01%) 0.189
Villous adenoma ≥ 10 mm 20 (0.09%) 13 (0.18%) 7 (0.04%) 0.003
Polyp with high grade dysplasia < 10 mm 108 (0.47%) 40 (0.55%) 68 (0.44%) 0.250
Polyp with high grade dysplasia ≥ 10 mm 125 (0.55%) 37 (0.51%) 88 (0.57%) 0.583
Invasive adenocarcinoma in polyp 25 (0.11%) 9 (0.12%) 16 (0.10%) 0.659
Non-epithelial malignant neoplasm 5 (0.02%) 1 (0.01%) 4 (0.03%) 0.928
Macroscopic adenocarcinoma 241 (1.05%) 87 (1.19%) 154 (0.99%) 0.158
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a linear correlation between ADR and withdrawal 
time, proving that a 6-minute withdrawal time is 
crucial to maintain the quality of the examination 
[23, 24].
The role of modern colonoscopy is to improve 
the quality by reducing the operator dependence. 
Within recent years different types of endoscop-
ic imaging techniques have been introduced to 
improve the quality in colonoscopy and as a con-
sequence the colorectal cancer screening. Ad-
vanced endoscopic imaging is revolutionizing our 
current methods to diagnose and treat colorectal 
lesions. 
One of the technologies that has become stan-
dard in modern endoscopy is high definition (HD). 
High definition endoscopes have more pixels than 
standard definition (SD). Improved image quality 
should improve lesion detection and recognition. 
High definition not only helps to visualize lesions 
during a  screening colonoscopy, but it also en-
hances evaluation of post-polypectomy scars at 
follow-up. A meta-analysis suggested that the im-
plementation of HD produces a 2% to 4% gain in 
the ADR [25]. In our study ADR in successive eras 
of endoscopic technological development has ris-
en. The difference in ADR between the analyzed 
eras is 2.59%, which is an acceptable level accord-
ing to the literature.
Another optical enhancement technology pres-
ent in modern endoscopes is filter technology that 
uses narrow red-green-blue light bands, i.e. nar-
row band imaging (NBI), to enhance micro-vessel 
architecture. There are randomized controlled tri-
als (RCTs) showing the improvement in ADR with 
the use of NBI compared to standard endoscopies. 
There is also one study suggesting that NBI may 
improve the learning curve for detecting flat le-
sions [26, 27]. Initial studies show that this tech-
nology has potential to improve ADR, but we defi-
nitely need further investigations. In our study we 
cannot determine what the real influence on ADR 
in group II was. Not every report contained the 
Kudo classification describing the found lesion. 
However, it was possible to use the NBI whenever 
the physician performing endoscopy had diagnos-
tic doubts. 
In our study we performed a multivariate logis-
tic regression analysis of the influence of selected 
factors on ADR, which showed that patients’ tol-
erance is one of the crucial elements. The mod-
ern endoscopes that we used in our study are 
equipped with tools that increase the tolerance of 
the patients. The variable stiffness of the endo-
scope and responsive insertion technology (RIT) 
are features simplifying endoscope insertion and 
reducing the discomfort and pain during the ex-
amination. Undesired loops are reduced when the 
RIT endoscope is used, because of the secondary 
bending section of the endoscope and its flexibil-
ity. In conventional colonoscopes, when the scope 
passes through a sharp flexure in the colon, the 
force applied by the physician when inserting the 
scope can sometimes directly push up the wall 
of the colon because the distal end of the scope 
bends with a  small radius (the so-called stick 
phenomenon). The bending function is useful for 
preventing the stick phenomenon, which causes 
severe pain for patients during colonoscopic in-
sertion in colonic flexures [28, 29]. Reduction of 
loop formation and auxiliary maneuvers when us-
ing RIT reduce the patients’ discomfort, leading to 
higher ADR. 
Another technology that has an impact on pa-
tients’ tolerance is magnetic endoscopic imaging 
(MEI) commercialized by Olympus as ScopeGuide 
(Olympus, Tokyo, Japan). Magnetic endoscopic 
imaging is a non-radiographic imaging technique 
capable of displaying real-time three-dimen-
sional images of the colonoscope shaft within 
the abdominal cavity [30]. The main advantage 
is the possibility to locate the lesions precisely. 
However, there are RCTs confirming that use of 
MEI during colonoscopy has the potential to ease 
cecal intubation, and reduce patient discomfort 
and dependence on sedation [31]. Also the MEI 
system appears to be beneficial for inexperi-
enced endoscopists, and it increases the cecal 
intubation rate. The technology helps to reduce 
the number of attempts to straighten loops and 
the duration of looping. However, experienced 
endoscopists are likely able to recognize and re-
solve loops quickly without the need for MEI vi-
sualization [32]. 
Colonoscopy is considered to be a  gold stan-
dard for CRC screening. However, we still have 
a  lot of work to do, especially considering the 
adenoma miss rate in the right colon. Many le-
sions are still missed because of the inability to 
visualize flat lesions and those located behind the 
fold. A  perfect device should be ergonomic, and 
effective in its results and costs [33, 34]. According 
to our experience technologies such as HD, NBI, 
RIT and MEI meet the above-mentioned criteria 
and enhance the quality of screening endosco-
py. There are several technologies present on the 
market, such as Full Spectrum Endoscopy (FUSE) 
and devices fixed to the colonoscope tip for the 
purpose of flattening folds, including a short cap 
or hood, Endocuff, Endocuff Vision, and Endoring. 
Our experience with those technologies is initial. 
Hence, we need more date to determine whether 
they can improve ADR. So far the data are mixed 
with regard to their efficacy.
In conclusion, there has been a  technological 
revolution in endoscopy since the beginning of 
our study in 2004. We showed that technological 
innovations, novel endoscopy devices and diag-
nostic techniques as well as patient-related fac-
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tors significantly improve the quality of colorec-
tal cancer screening by increasing the adenoma 
detection rate. Endoscopes of the new era have 
great potential. However, in the future, we need to 
determine and standardize which of the technolo-
gies are supreme to achieve excellence in colorec-
tal cancer screening.
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